New Technology– category –
-
Machine Learning Accelerates Lipid Nanoparticle Design, Streamlining RNA Therapeutic Formulation Development for High Efficacy and Reduced Experimental Burden
Pharmatica USA Overview Machine learning (ML) is being applied to lipid nanoparticle (LNP) design to accelerate formulation development, improve delivery performance, and reduce experimental burden for RNA therapeutics, gene-editing syst... -
Asia-Pacific AI Drug Discovery Platforms Mature, Achieving Key Clinical Milestones
BioPharma APAC Asia-Pacific Overview AI drug discovery platforms in the Asia-Pacific region are demonstrating significant clinical traction, with Hummingbird Bioscience initiating patient dosing for its HER3-targeted ADC and Insilico Med... -
AI Drug Discovery Cuts Development Time to 18 Months, Insilico Medicine Achieves 99% Cost Reduction for Novel Candidates
BCC Research USA Overview AI is dramatically accelerating drug discovery, shortening the timeline from a decade to under 18 months, with Insilico Medicine identifying a drug candidate for just $2.6 million—a 99% cost saving. This rapid a... -
AlphaFold2’s Protein Structure Prediction Breakthrough Earns Nobel Prize, Igniting New Era in AI-Driven Drug Discovery
Facebook (Singularity University) UK Overview Google DeepMind's AlphaFold achieved a groundbreaking advance in protein structure prediction in 2020, leading to a Nobel Prize in 2024 for David Baker, Demis Hassabis, and John Jumper. This ... -
Backbone-Ionized Polymer iPβAE Quantitatively Guides Extra-Hepatic mRNA Expression to Spleen and Lung
Journal of the American Chemical Society USA Overview A study published in the Journal of the American Chemical Society introduces a backbone-ionized polymer (iPβAE) platform engineered for quantitatively guided extra-hepatic mRNA target... -
Tamarind Bio and GenScript Partner to Accelerate Drug Discovery by Connecting AI Molecular Design with Rapid Wet-Lab Validation
Facebook (from GenScript Biotech) USA Overview AI-driven drug design, particularly using generative models like GANs and VAEs, accelerates drug discovery by generating novel molecular structures with desired properties. These systems ana... -
Transferrin-Conjugated Polymeric Nanoparticles via PISA Enhance BBB Transport and Doxorubicin Delivery for Glioblastoma Therapy
ACS Publications USA Overview Researchers have developed transferrin-conjugated polymeric nanoparticles, synthesized via polymerization-induced self-assembly (PISA), for enhanced blood-brain barrier (BBB) penetration and glioblastoma (GB... -
Scaffold-Aware Transformer with Multi-Scale Attention Accelerates Novel Molecular Design
PMC (Part of MDPI) Switzerland Overview Researchers propose a novel framework for de novo molecular design that integrates a transformer-based generative model and a graph attention network-based predictive model, featuring a scaffold-aw... -
Structure-Aware AI Accelerates Next-Gen Drug Discovery: From 3D Molecular Geometry to Generative Biomolecular Design
Briefings in Bioinformatics | Oxford Academic UK Overview Structure-aware AI systems, leveraging graph neural networks, Transformer-based models, and diffusion-based generative models, are advancing next-generation drug discovery. These ... -
Organ-on-Chip Platforms Accelerate Nanoparticle DDS Development: Revolutionizing Preclinical Predictive Power
Biophysics Reviews | AIP Publishing USA Overview While nanoparticle-based drug delivery systems (DDS) have advanced significantly, their preclinical evaluation's predictive power has been a bottleneck. The integration of nanoparticles wi...
